Načítá se...
The current role of cytoreductive nephrectomy for metastatic renal cell carcinoma
The management of metastatic renal cell carcinoma (mRCC) continues to be a therapeutic challenge; however, the options for systemic therapy in this setting have exploded over the past 20 years. From the advent of toxic cytokine therapy to the subsequent discovery of targeted therapy (TT) and immune...
Uloženo v:
| Vydáno v: | Indian J Urol |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Wolters Kluwer - Medknow
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8033221/ https://ncbi.nlm.nih.gov/pubmed/33850351 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/iju.IJU_293_20 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|